GlassScriptPhysician profile
Sarah Seeburger
NPI 1679960546
$1,028.68
in general payments reported to CMS, 2019-2025
14 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $126 · 2022: $305 · 2023: $270 · 2024: $157 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.62 | 2021-2025 | |
| Astellas Pharma US INC | $106.34 | 2021-2025 | Veozah |
| Hologic Sales and Service, LLC | $89.56 | 2022-2025 | Thinprep 2000 Processor, Biozorb, Novasure |
| Myriad Women'S Health, INC. | $65.64 | 2023 | Myrisk |
| Biogen, INC. | $58.72 | 2024-2025 | Zurzuvae |
| Organon LLC | $52.07 | 2023-2024 | Nexplanon, Nuvaring |
| Becton, Dickinson and Company | $48.29 | 2022 | |
| Pfizer INC. | $47.72 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.57 | 2025 | |
| Agile Therapeutics, INC. | $28.16 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $26.56 | 2023 | |
| Medtronic, INC. | $23.03 | 2023 | Truclear |
| Ascend Therapeutics US, LLC | $19.26 | 2021 | |
| Evofem Biosciences, INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Seeburger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.